Tolcapone-Related Liver Dysfunction
- 1 January 2003
- journal article
- review article
- Published by Springer Nature in Drug Safety
- Vol. 26 (11) , 743-747
- https://doi.org/10.2165/00002018-200326110-00001
Abstract
Levodopa is the cornerstone of idiopathic Parkinson’s disease (PD) treatment. However, after long-term use of levodopa, a significant percentage of patients experience motor fluctuations, which...Keywords
This publication has 27 references indexed in Scilit:
- Switch-Over from Tolcapone to Entacapone in Severe Parkinson’s Disease PatientsEuropean Neurology, 2001
- Entacapone enhances the response to levodopa in parkinsonian patients with motor fluctuationsNeurology, 1998
- Tolcapone and fulminant hepatitisThe Lancet, 1998
- Tolcapone added to levodopa in stable parkinsonian patients: A double‐blind placebo‐controlled studyMovement Disorders, 1997
- Entacapone improves motor fluctuations in levodopa‐ treated Parkinson's disease patientsAnnals of Neurology, 1997
- Tolcapone in stable Parkinson's disease: Efficacy and safety of long-term treatmentNeurology, 1997
- Tolcapone Improves Motor Function and Reduces Levodopa Requirement in Patients with Parkinson's Disease Experiencing Motor FluctuationsNeurology, 1997
- TolcaponeCNS Drugs, 1996
- Catechol‐O‐methyltransferase inhibitor tolcapone prolongs levodopa/carbidopa action in parkinsonian patientsNeurology, 1993
- Pharmacokinetics of LevodopaClinical Neuropharmacology, 1984